IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PECORELLI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.330
AS - Asia 5.692
EU - Europa 4.818
SA - Sud America 1.100
Continente sconosciuto - Info sul continente non disponibili 467
AF - Africa 125
OC - Oceania 14
AN - Antartide 1
Totale 29.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.948
CN - Cina 2.178
SG - Singapore 1.745
UA - Ucraina 1.314
BR - Brasile 889
IT - Italia 737
DE - Germania 638
HK - Hong Kong 586
PL - Polonia 429
FI - Finlandia 427
VN - Vietnam 336
FR - Francia 299
GB - Regno Unito 293
CA - Canada 220
TR - Turchia 212
IN - India 205
IE - Irlanda 197
RU - Federazione Russa 188
BD - Bangladesh 110
SE - Svezia 77
AR - Argentina 70
IQ - Iraq 52
MX - Messico 48
NL - Olanda 39
JP - Giappone 37
ID - Indonesia 36
EC - Ecuador 35
ZA - Sudafrica 35
ES - Italia 34
EE - Estonia 32
VE - Venezuela 32
SA - Arabia Saudita 26
BE - Belgio 23
CO - Colombia 21
AT - Austria 19
LT - Lituania 19
MU - Mauritius 19
PK - Pakistan 18
CL - Cile 17
CR - Costa Rica 17
MA - Marocco 17
EU - Europa 16
JM - Giamaica 16
AE - Emirati Arabi Uniti 15
AU - Australia 13
IL - Israele 13
PY - Paraguay 13
SV - El Salvador 13
UZ - Uzbekistan 13
IR - Iran 12
CZ - Repubblica Ceca 11
NP - Nepal 11
UY - Uruguay 11
TN - Tunisia 10
TT - Trinidad e Tobago 10
HN - Honduras 9
KG - Kirghizistan 9
AZ - Azerbaigian 8
GT - Guatemala 8
KE - Kenya 8
KZ - Kazakistan 8
NG - Nigeria 8
PR - Porto Rico 8
TW - Taiwan 8
BB - Barbados 7
CH - Svizzera 7
CW - ???statistics.table.value.countryCode.CW??? 7
JO - Giordania 7
KR - Corea 7
SC - Seychelles 7
EG - Egitto 6
PE - Perù 6
PT - Portogallo 6
DZ - Algeria 5
MY - Malesia 5
AL - Albania 4
BH - Bahrain 4
BO - Bolivia 4
GE - Georgia 4
GP - Guadalupe 4
LK - Sri Lanka 4
LV - Lettonia 4
NI - Nicaragua 4
OM - Oman 4
PS - Palestinian Territory 4
RO - Romania 4
TH - Thailandia 4
BG - Bulgaria 3
BS - Bahamas 3
GR - Grecia 3
LU - Lussemburgo 3
PA - Panama 3
PH - Filippine 3
AG - Antigua e Barbuda 2
AO - Angola 2
BM - Bermuda 2
BY - Bielorussia 2
BZ - Belize 2
ET - Etiopia 2
GA - Gabon 2
Totale 29.075
Salva come PNG Salva come JPEG
Città #
Ashburn 1.678
Fairfield 1.663
Woodbridge 1.636
Houston 1.150
Singapore 943
Jacksonville 920
Ann Arbor 800
Wilmington 766
Seattle 711
Cambridge 647
San Jose 617
Hong Kong 564
Council Bluffs 456
Warsaw 422
Beijing 393
New York 383
Chandler 365
Nanjing 354
Princeton 353
Los Angeles 308
The Dalles 302
Dearborn 212
Helsinki 212
Dublin 196
Dallas 167
Istanbul 163
Lauterbourg 155
Columbus 141
Nanchang 128
Ho Chi Minh City 127
Des Moines 118
São Paulo 103
San Francisco 101
Moscow 100
Santa Clara 98
Chicago 95
San Diego 91
Shenyang 87
Milan 77
Changsha 76
Buffalo 73
Orem 73
Munich 72
Shanghai 72
Toronto 69
Hebei 67
Kunming 67
Denver 63
Hanoi 63
Jinan 60
Jiaxing 59
Redondo Beach 59
Tianjin 55
Phoenix 54
London 53
Brescia 52
Montreal 47
Brooklyn 46
Hangzhou 45
Atlanta 40
Rome 40
North Bergen 36
Chennai 31
Indianapolis 31
Verona 31
Tokyo 29
Turku 29
Zhengzhou 28
Charlotte 26
Ningbo 25
Rio de Janeiro 25
Tallinn 24
Boston 23
Nuremberg 23
Belo Horizonte 22
Hefei 22
Brasília 21
Lancaster 21
Washington 21
Lanzhou 20
Monmouth Junction 20
Stockholm 20
Brussels 19
Guangzhou 19
Amsterdam 18
Mexico City 18
Mumbai 18
Taizhou 18
Miami 17
Orange 17
Poplar 17
Porto Alegre 17
Pune 17
Baghdad 16
Dong Ket 16
Frankfurt am Main 16
Johannesburg 16
Norwalk 16
Philadelphia 16
Manchester 15
Totale 19.941
Salva come PNG Salva come JPEG
Nome #
Cancer-related anemia: pathogenesis, prevalence and treatment. 1.217
Bambini pretermine: nati per vivere 375
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 375
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 347
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in adolescents in Northern Italy: an observational school-based study. 322
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 303
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor 245
OVEREXPRESSION OF CLOSTRIDIUM PERFRINGENS ENTEROTOXIN RECEPTORS CLAUDIN-3 AND CLAUDIN-4 IN UTERINE CARCINOSARCOMAS. 234
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 230
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 227
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 220
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 219
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 218
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 212
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 212
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 212
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 211
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). 202
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women 202
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 200
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. 199
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas 198
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 197
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 195
DEVELOPMENT AND THERAPEUTIC EFFECT OF ADOPTIVELY TRANSFERRED T CELLS PRIMED BY TUMOR LYSATE-PULSED AUTOLOGOUS DENDRITIC CELLS IN A PATIENT WITH METASTATIC ENDOMETRIAL CANCER. 193
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 189
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 188
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 187
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 187
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 187
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 184
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 180
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 178
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 178
Consolidation therapies revisited: weekly paclitaxel 178
Mammaglobin B expression in human endometrial cancer 177
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). 175
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency 175
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 174
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 174
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody 174
Chlamydia trachomatis genotypes in school adolescents, Italy 174
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab. 173
ADVANCES IN DENDRITIC-CELL-BASED THERAPEUTIC VACCINES FOR CERVICAL CANCER. 173
Carcinoma of the Fallopian tube 171
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 170
Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board 170
TUMOR-INFILTRATING LYMPHOCYTES CONTAIN HIGHER NUMBERS OF TYPE 1 CYTOKINE EXPRESSORS AND DR+ T CELLS COMPARED WITH LYMPHOCYTES FROM TUMOR DRAINING LYMPH NODES AND PERIPHERAL BLOOD IN PATIENTS WITH CANCER OF THE UTERINE CERVIX. 168
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin. 167
Racial differences in overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in Uterine Serous Papillary Cancer 166
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor 166
HPV vaccination acceptability in young boys 166
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 166
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities. 165
Toward appropriate criteria in medication adherence assessment in older persons: Position Paper 164
Carcinoma of the corpus uteri 163
IN VITRO INDUCTION OF TUMOR-SPECIFIC HUMAN LYMPHOCYTE ANTIGEN CLASS I-RESTRICTED CD8 CYTOTOXIC T LYMPHOCYTES BY OVARIAN TUMOR ANTIGEN-PULSED AUTOLOGOUS DENDRITIC CELLS FROM PATIENTS WITH ADVANCED OVARIAN CANCER. 162
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression. 162
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 162
Early stage cervical cancer: adjuvant treatment in negative lymph node cases. 161
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer 159
Revised FIGO staging for carcinoma of the vulva, cervix, andendometrium. 159
INDUCTION OF OVARIAN TUMOR-SPECIFIC CD CYTOTOXIC T LYMPHOCYTES BY ACID-ELUTED PEPTIDE-PULSED AUTOLOGOUS DENDRITIC CELLS 157
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2) 157
Carcinoma of the Fallopian tube 157
Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer 156
Prescription drug use among older adults in Italy: A country-wide perspective 156
Claudin-7 expression in human epithelial ovarian cancer 156
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 156
EXPRESSION PATTERN AND MOLECULAR FUNCTION OF TRASCRIPTION FACTOR FOXM1 (FORKHEAD BOX PROTEIN M1) IN EPITHELIAL OVARIAN CANCER CLINICAL SPECIMENS AND CELL LINES 154
Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight 153
Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy 152
Interval Cytoreduction in Ovarian Cancer 152
Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. 152
Mental health and the global agenda. 151
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 151
Hearing loss and cognitive decline in older adults: Questions and answers 150
Scaling up health knowledge at European level requires sharing integrated data: An approach for collection of database specification 150
Early stage ovarian cancer: the Italian contribution to clinical research. An update 150
Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 149
INCREASED LEVELS OF INTERLEUKIN-10 AND TRANSFORMING GROWTH FACTOR-BETA IN THE PLASMA AND ASCITIC FLUID OF PATIENTS WITH ADVANCED OVARIAN CANCER. 149
Replacement therapy for breast cancer survivors. A pilot study 149
New development of the FIGO staging system. 148
Staging classification for cancer of the ovary, fallopian tube, and peritoneum 147
Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu. 146
Carcinoma of the corpus uteri 146
High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA) 145
Time to face the challenge of multimorbidity. A European perspective from the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS) 145
OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE-1 RECEPTOR (EGF-R1) IN CERVICAL CANCER: IMPLICATIONS FOR CETUXIMAB-MEDIATED THERAPY IN RECURRENT/METASTATIC DISEASE. 144
Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 144
High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody. 144
Interventional tools to improve medication adherence: Review of literature 144
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial. 142
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. 142
Carcinoma of the fallopian tube. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 141
Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administrationof Clostridium perfringens enterotoxin. 141
Interval debulking surgery in advanced epithelial ovarian cancer 140
Gestational trophoblastic diseases 140
History of the FIGO cancer staging system 139
Carcinoma of the ovary 138
Totale 18.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.528
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.093 0 0 0 0 11 106 77 88 77 292 123 319
2022/20231.190 240 30 50 69 83 343 10 94 153 11 52 55
2023/20241.512 78 35 145 108 82 358 49 60 330 57 20 190
2024/20252.699 19 31 10 379 308 265 188 77 264 165 622 371
2025/20267.101 674 835 421 1.007 610 393 884 199 331 463 1.219 65
2026/20272.066 273 275 456 920 142 0 0 0 0 0 0 0
Totale 29.547